733.8000 6.35 (0.87%)
NSE Oct 16, 2025 15:56 PM
Volume: 169.1K
 

Axis Direct
We believe KIMS has a structural growth story (strong ROCE of 32%). It is also a zero net-debt company due to its strong operating cash flow generation. Keeping this in perspective, we recommend a BUY rating on the stock with a TP of Rs 1,570/share.
Krishna Institute of Medical Sciences Ltd.'s price crossed above 30Day SMA today
More from Krishna Institute of Medical Sciences Ltd.
Recommended